The use of intracameral antibiotics - specifically intracameral moxifloxacin - has become relatively mainstream practice in cataract surgery. But how effective is it in preventing endophthalmitis? Are ophthalmologists administering it correctly? And what are some of the potential adverse effects that can result from intracameral moxifloxacin? Leading expert in the field, Dr. Steve Arshinoff, joins the podcast.
This episode is sponsored by Thea Pharma Canada - https://www.theapharma.ca
Podden och tillhörande omslagsbild på den här sidan tillhör
Zale Mednick. Innehållet i podden är skapat av Zale Mednick och inte av,
eller tillsammans med, Poddtoppen.
